Zhang Nan, Wu Biqi, Boschelli Diane H, Golas Jennifer M, Boschelli Frank
Chemical Sciences, Wyeth Research, Pearl River, NY 10965, USA.
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5071-4. doi: 10.1016/j.bmcl.2009.07.043. Epub 2009 Jul 10.
A series of 4-anilino-7-pyridyl-3-quinolinecarbonitriles was prepared as Src kinase inhibitors. A systematic SAR study of substitutions on both the pyridine ring and the 3-quinolinecarbonitrile core established the requirements for optimal activity. The lead compound, 17, showed potent activity in both the Src enzyme assay and cell assays, and demonstrated in vivo anti-tumor activity in a xenograft model.
制备了一系列4-苯胺基-7-吡啶基-3-喹啉甲腈作为Src激酶抑制剂。对吡啶环和3-喹啉甲腈核心上的取代基进行了系统的构效关系研究,确定了最佳活性的要求。先导化合物17在Src酶分析和细胞分析中均显示出强效活性,并在异种移植模型中表现出体内抗肿瘤活性。